Method Of Treating Genetic Disease Caused By Nonsense Mutation
申请人:Matsuda Ryoichi
公开号:US20100093867A1
公开(公告)日:2010-04-15
An object of the present invention is to provide compounds having read-through activity for use in treatment methods of genetic diseases caused by nonsense mutation, to provide pharmaceutical compositions comprising the compound, and to provide a treatment method of genetic diseases caused by nonsense mutation comprising administering the compound.
The present invention can provide a method of producing wild type normal protein in a living body of a mammal from a gene with a premature termination codon being generated by a mutation, wherein the method comprises administering a compound expressed by the following formula (VI):
(wherein R
1
, R
2
, R
3
, R
4
, R
5
and X
1
in the formula are as defined in description) or the like to the mammal.
Synthesis, Variable Temperature and Pressure 17O NMR Study of Bis(alkylamide) Derivatives of [(Gd-DTPA)(H2O)]2 − An Assessment of the Substitution Effect on Water Exchange Kinetics
作者:François Botteman、Gaëlle M. Nicolle、Luce Vander Elst、Sophie Laurent、André E. Merbach、Robert N. Muller